albendazole has been researched along with epiglucan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dymon, M; Papir, B | 1 |
| Dvoroznáková, E; Porubcová, J; Sevcíková, Z | 1 |
| Eid, MM; El-Kowrany, SI; Elgendy, DI; Mohamed, DA; Othman, AA; Sallam, FA; Zineldeen, DH | 1 |
3 other study(ies) available for albendazole and epiglucan
| Article | Year |
|---|---|
[Effect of anthelmintic therapy supplemented with glucan in experimental toxocarosis].
Topics: Albendazole; Animals; Anthelmintics; beta-Glucans; Brain; Diethylcarbamazine; Drug Therapy, Combination; Immunologic Factors; Larva; Liposomes; Male; Mebendazole; Mice; Muscle, Skeletal; Toxocara canis; Toxocariasis; Treatment Outcome | 2004 |
Immunomodulative effect of glucan and/or glucan supplemented with zinc in albendazole therapy for murine alveolar echinococcosis.
Topics: Albendazole; Animals; Antiparasitic Agents; B-Lymphocytes; beta-Glucans; Dietary Supplements; Drug Therapy, Combination; Echinococcosis, Pulmonary; Lymphocyte Activation; Male; Mice; Proteoglycans; Pulmonary Alveoli; Specific Pathogen-Free Organisms; T-Lymphocytes; Treatment Outcome; Zinc | 2007 |
The impact of β-glucan on the therapeutic outcome of experimental Trichinella spiralis infection.
Topics: Albendazole; Animals; Anti-Inflammatory Agents; beta-Glucans; Humans; Larva; Mice; Muscle, Skeletal; NF-kappa B; Treatment Outcome; Trichinella spiralis; Trichinellosis | 2023 |